Sentrysciences, Inc.

Longmont, CO

UEI
K63NCNGKLCX5
CAGE
9AXE6
Primary NAICS
513210 Software Publishers
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1551 S Sunset St b, Longmont, CO 80501, USA
Website
sentrysci.com
Founded
2011
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
50 Wholesale Trade – Durable Goods
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $55,000
FY2025 $0
FY2024 $0
FY2023 $16,468

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $55,000

Contract awards

Grant subawards

Prime recipient Prime award Amount Awarded
University Of Delaware Evaluation of an automated vapor phase hydrogen peroxide decontamination system for rapid, non-residual decontamination of clinical spaces. 70NANB21H085 $40,420

Similar vendors

About the company

Sentrysciences, Inc., doing business as Sentrysciences LLC, is a Colorado-based for-profit company that develops artificial intelligence and computational statistics platforms for life-sciences applications, operating as a prime contractor on federal purchase orders with no set-aside designation. The vendor has received three recent federal awards totaling $71 thousand in combined potential value across two prime contracts and one sub-award grant, with activity spanning the Food and Drug Administration, the Defense Health Agency, and the National Institute of Standards and Technology.

Sentrysciences' concrete capability footprint centers on machine-learning platforms for biosimilar drug characterization and medical device analysis. The vendor's largest recent award — a $55 thousand purchase order from FDA issued June 15, 2026, with ultimate completion June 14, 2027 — funds an artificial intelligence and computational statistics platform designed to detect and classify protein aggregates in biosimilar drug products. The platform generates morphological fingerprints of protein aggregates, differentiates particles by stress type and product, and employs neural network-based metric learning to characterize subvisible particles under 100 microns. The system is compatible with Flow Imaging and Backgrounded Membrane Imaging data and includes statistical analysis tools such as Euclidian distance and Kolmogorov-Smirnov test similarity scores; Sentrysciences also provides training for FDA staff on AI/ML application and result interpretation. The vendor's second prime award, a $16.5 thousand purchase order from the Defense Health Agency issued June 29, 2023, supplied AEROTRAK 9306-V2 handheld air particle counters for military health system programs at Fort Sam Houston, Texas. In its sub-award role, Sentrysciences participated in a University of Delaware federal grant focused on evaluation of automated vapor phase hydrogen peroxide decontamination systems for clinical spaces, awarded November 23, 2021.

Customer concentration is thin. FDA and the Defense Health Agency account for all named dollar value across the three-award footprint, with FDA's $55 thousand order representing 77% of combined potential value. One award — the FDA purchase order — faces recompete within the next twenty-four months.

Quick answers

Is Sentrysciences, Inc. registered in SAM.gov?

Yes. Sentrysciences, Inc.'s SAM.gov registration is active through March 2, 2027.

What is Sentrysciences, Inc.'s CAGE code?

Sentrysciences, Inc.'s CAGE code is 9AXE6, and its Unique Entity ID (UEI) is K63NCNGKLCX5.

How much has Sentrysciences, Inc. received in federal contracts?

Federal contracts obligated $71,468 to Sentrysciences, Inc. in fiscal years 2023 through 2027.

What is Sentrysciences, Inc.'s most recent federal award?

Sentrysciences, Inc.'s most recent federal contract award is Artificial intelligence and computational statistics platform for biosimilar subvisible characterization (75F40126P00070), from Food and Drug Administration, on June 15, 2026.

On GovTribe

See Sentrysciences, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe